<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>CTL are thought to play a role in the elimination of transformed cells in vivo </plain></SENT>
<SENT sid="1" pm="."><plain>The effectiveness of such CTL is in part dependent on recognition of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> specific antigens </plain></SENT>
<SENT sid="2" pm="."><plain>Among the best characterized <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-specific antigens are the unique or idiotypic determinants on the Ig of B cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Here we describe the generation and properties of human CTL specific for the idiotype on autologous B cell <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>These cells are CD3+,CD4-,CD8- and express the delta chain of the TCR </plain></SENT>
<SENT sid="5" pm="."><plain>Such cells may prove useful in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-specific adoptive therapy </plain></SENT>
</text></document>